Bioequivalence Study of Prednisolone and Dexamethasone

Last updated: April 4, 2022
Sponsor: University Medical Center Groningen
Overall Status: Active - Recruiting

Phase

1

Condition

Healthy Volunteers

Treatment

N/A

Clinical Study ID

NCT04733144
201900874
2019-004983-23
  • Ages 18-75
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The purpose of this study is to compare two different glucocorticoids, prednisolone and dexamethasone at two different doses for their organ specific effects, utilizing modern day standards.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Participants must be healthy with no relevant medical history and no use ofmedication.
  • Female participants aged <50 years must be using oral contraceptives and femaleparticipants age ≥50 years must be in the postmenopausal state
  • Command of the Dutch language
  • Providing written IC
  • BMI between 18.5 and 30 kg/m2
  • Participants must be between 18 and 75 years of age

Exclusion

Exclusion Criteria:

  • Potential participants who are unlikely to adhere to the study protocol (for instancesubjects which have a history of substance abuse or non-compliance)
  • Potential participants with a medical history of:
  1. Diseases affecting the HPA-axis: e.g. primary and secondary adrenalinsufficiency, pituitary tumors, and nightshift workers
  2. Diseases affecting the HPG-axis: e.g. Cushing disease.
  3. Chronic inflammatory diseases: e.g. rheumatoid arthritis, polymyalgia rheumatic,and asthma
  4. Psychiatric diseases
  5. Diabetes
  • Shift workers
  • Potential participants with a kidney function <60 ml/min/1.73m2, abnormalities inliver enzymes, and/or abnormalities in thyroid function
  • Potential participants who are dependent on corticosteroids, e.g. asthmatic patients,and transplant recipients

Study Design

Total Participants: 24
Study Start date:
March 04, 2021
Estimated Completion Date:
May 31, 2022

Study Description

Study design: A randomised, double blind, cross-over clinical trial.

Study population: healthy human adult volunteers including 12 males and 12 females aged 18-75 years old.

Intervention: In random order, subjects will receive 7,5 mg prednisolone for one week, directly followed by 30 mg of prednisolone for one week. After a washout period of 4 weeks (or by exception 8 weeks), subjects will receive 1,125 mg dexamethasone for one week, directly followed by 4,5 mg dexamethasone for one week.

Main study parameters/endpoints: The main study endpoint is the difference in total urinary cortisol excretion as measured in 24h-urine between the lower doses of prednisolone and dexamethasone as well as between the higher doses of prednisolone and dexamethasone.

Connect with a study center

  • University Medical Center Groningen

    Groningen, 9713 GZ
    Netherlands

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.